Illumina to Buy Gates, Bezos-Backed Grail in $8 Billion Deal

Published September 21, 2020

Illumina Inc.’s shares fell after the genetic sequencing giant agreed to acquire Grail Inc. in a deal valuing the cancer-detection startup at $8 billion.